These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7469196)

  • 1. [Dystonia and carbamazepine (author's transl)].
    Martinón JM; Docampo G; Martinón F; Viso JA; Peña J
    An Esp Pediatr; 1980 Sep; 13(9):789-92. PubMed ID: 7469196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystonia associated with carbamazepine administration: experience in brain-damaged children.
    Crosley CJ; Swender PT
    Pediatrics; 1979 Apr; 63(4):612-5. PubMed ID: 440873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on carbamazepine serum level in epileptic patients treated only with carbamazepine: with special reference to its efficacy and side effects (author's transl)].
    Kaneko S; Suzuki K; Fukushima Y; Sato T
    Seishin Shinkeigaku Zasshi; 1978 Sep; 80(9):537-60. PubMed ID: 724824
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbamazepine serum levels in epileptics. Influence of age, sex, body weight and interaction with phenobarbital.
    De Michele G; Brescia Morra V; Pisanti N; Giani U; Filla A; Sinisi L; Capone D; Campanella G
    Acta Neurol (Napoli); 1985; 7(3-4):228-34. PubMed ID: 4061136
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lipid levels during carbamazepine therapy in epileptic children.
    Mahmoudian T; Iranpour R; Messri N
    Epilepsy Behav; 2005 Mar; 6(2):257-9. PubMed ID: 15710313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies in children with epilepsy treated by carbamazepine.
    Asadi-Pooya AA; Asadi-Pooya K
    Epilepsy Res; 2008 Aug; 80(2-3):229-30. PubMed ID: 18490144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent dystonia associated with carbamazepine therapy: a case report.
    Lee JW
    N Z Med J; 1994 Sep; 107(985):360-1. PubMed ID: 8078626
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine-induced dystonia in an adolescent.
    Bansal S; Gill M; Bhasin C
    Indian J Pharmacol; 2016; 48(3):329-30. PubMed ID: 27298509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ; Lin KL; Wang HS; Wang CJ
    Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children.
    Yilmaz E; Doşan Y; Gürgöze MK; Güngör S
    Acta Neurol Belg; 2001 Dec; 101(4):217-20. PubMed ID: 11851028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
    Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K
    Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbamazepine therapy on serum lipids in children with partial epilepsy.
    Aggarwal A; Singh V; Batra S; Faridi MM; Sharma S
    Pediatr Neurol; 2009 Feb; 40(2):94-7. PubMed ID: 19135621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carbamazepine & its combinations on thyroid functions in epileptics.
    Maheshwari MC; Kouchupillai N; Jailkhani BL; Gupta SK
    Indian J Med Res; 1984 Jan; 79():76-9. PubMed ID: 6724655
    [No Abstract]   [Full Text] [Related]  

  • 18. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
    Wesnes KA; Edgar C; Dean AD; Wroe SJ
    Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary anticonvulsant levels in children with epilepsy.
    Day RE; Chambers RE
    Br J Clin Pract; 1981 Jan; 35(1):25-9. PubMed ID: 7259942
    [No Abstract]   [Full Text] [Related]  

  • 20. Acoustic effects of carbamazepine in benign rolandic epilepsy.
    Park JI; Kim SJ; Kim HG
    Epilepsy Behav; 2005 Nov; 7(3):468-71. PubMed ID: 16140591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.